| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chy is a comprehensive herbal tonic, prepared from around 50 herbs employing anwala (Emblica officinalis) as the basic ingredient Chyawanprash — a traditional Ayurvedic polyherbal rasayana formulated as a semisolid herbal-food preparation, typically using amla/Indian gooseberry (Phyllanthus emblica, syn. Emblica officinalis) as the principal botanical together with several dozen herbs, spices, honey or sugar, ghee, and sesame oil. It is best classified as a complex polyherbal nutraceutical/traditional Ayurvedic formulation rather than as a single pharmacologically defined drug. Standard abbreviations include CP and Chy. Composition varies substantially among classical recipes and commercial products, making biological effects formulation-dependent. Unlike amla or an isolated phytochemical, Chyawanprash has no single defined active ingredient or validated molecular target. Primary mechanisms (ranked):
Bioavailability / PK relevance: Chyawanprash has no clinically established whole-formulation pharmacokinetic profile because it contains many chemically distinct constituents. Piperine-containing herbs, lipids from ghee/sesame oil, and the complex food matrix may alter absorption of individual phytochemicals, but quantitative systemic exposure cannot be inferred from the administered gram dose. Commercial formulations should not be assumed bioequivalent. In-vitro vs systemic exposure relevance: Direct comparison between in-vitro concentrations and achievable systemic Chyawanprash exposure is generally inappropriate because Chyawanprash is a multicomponent formulation rather than a defined molecule. Mechanistic effects attributed to isolated constituents such as polyphenols, flavonoids, piperine, or amla-derived compounds should not automatically be attributed to achievable concentrations after oral Chyawanprash consumption. Clinical evidence status: Small human studies and several randomized studies exist for general health, immunity, metabolic endpoints, respiratory/infectious settings, and COVID-19 prophylaxis. Cancer evidence is very limited and does not demonstrate treatment of established malignancy. A small study in patients with betel-associated oral premalignant lesions found improved cytogenetic markers when Chyawanprash was added to betel cessation, supporting possible genoprotective/chemopreventive activity rather than anticancer efficacy. Chyawanprash should therefore be categorized as human evidence for supportive/general health effects; preliminary chemopreventive evidence; no established anticancer therapy. Safety / formulation constraint: Safety is product-dependent. Traditional formulations contain substantial sugar or honey and may be relevant to patients with diabetes or carbohydrate restriction. Because Ayurvedic products vary in manufacturing quality, contamination with lead, mercury, arsenic, undeclared drugs, or other contaminants is an important product-selection concern; regulated and independently tested products are preferable. Potential herb-drug interactions are difficult to predict because of the large number of ingredients. Chyawanprash Cancer-Relevant Mechanisms
|
| Source: |
| Type: |
| Glutathione (GSH) is a thiol antioxidant that scavenges reactive oxygen species (ROS), resulting in the formation of oxidized glutathione (GSSG). Decreased amounts of GSH and a decreased GSH/GSSG ratio in tissues are biomarkers of oxidative stress. Glutathione is a powerful antioxidant found in every cell of the body, composed of three amino acids: cysteine, glutamine, and glycine. It plays a crucial role in protecting cells from oxidative stress, detoxifying harmful substances, and supporting the immune system. cancer cells can have elevated levels of glutathione, which may help them survive in the oxidative environment created by the immune response and chemotherapy. This can make cancer cells more resistant to treatment. While glutathione can be obtained from certain foods (like fruits, vegetables, and meats), its absorption from supplements is debated. Some people take N-acetylcysteine (NAC) or other precursors to boost glutathione levels, but the effects on cancer prevention or treatment are still being studied. Depleting glutathione (GSH) to raise reactive oxygen species (ROS) is a strategy that has been explored in cancer research and therapy. Many cancer cells have altered redox states and may rely on GSH to survive. Increasing ROS levels can induce stress in these cells, potentially leading to cell death. Certain drugs and compounds can deplete GSH levels. For example, agents like buthionine sulfoximine (BSO) inhibit the synthesis of GSH, leading to its depletion. Cancer cells tend to exhibit higher levels of intracellular GSH, possibly as an adaptive response to a higher metabolism and thus higher steady-state levels of reactive oxygen species (ROS). "...intracellular glutathione (GSH) exhibits an astounding antioxidant activity in scavenging reactive oxygen species (ROS)..." "Cancer cells have a high level of GSH compared to normal cells." "...cancer cells are affluent with high antioxidant levels, especially with GSH, whose appearance at an elevated concentration of ∼10 mM (10 times less in normal cells) detoxifies the cancer cells." "Therefore, GSH depletion can be assumed to be the key strategy to amplify the oxidative stress in cancer cells, enhancing the destruction of cancer cells by fruitful cancer therapy." The loss of GSH is broadly known to be directly related to the apoptosis progression. |
| 7406- | Chy, | Antiamnesic activity of an ayurvedic formulation chyawanprash in mice |
| - | in-vivo, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:449 Target#:137 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid